60 results
8-K
EX-99.1
UBX
Unity Biotechnology Inc
15 Apr 24
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
7:00am
was primarily due to decreases of $2.5 million in personnel-related expenses due to the Company's reduced headcount, partially offset by an increase of $0.6
8-K
EX-99.1
UBX
Unity Biotechnology Inc
13 Nov 23
UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results
4:05pm
and accounting service fees, partially offset by $0.3 million increase in operating costs mainly from the discontinuation of sublease income generated from
8-K
EX-99.1
mvkjax1t3cumfh jf
8 Aug 23
UNITY Biotechnology, Inc. Reports Second Quarter 2023 Financial Results
4:04pm
8-K
EX-99.1
5on9tmf9h
9 May 23
UNITY Biotechnology, Inc. Reports First Quarter 2023 Financial Results
4:10pm
8-K
EX-99.1
ekyy31k
8 Nov 22
UNITY Biotechnology, Inc. Reports Third Quarter 2022
4:09pm
424B5
hpj0 xfbt9x8l
19 Aug 22
Prospectus supplement for primary offering
8:42am
FWP
ymr4n01poncqqq
17 Aug 22
Free writing prospectus
5:15pm
424B5
c0cmwg9
16 Aug 22
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
bzo29ykfh 82hpttd2x
10 May 22
UNITY Biotechnology, Inc. Reports First Quarter 2022
4:01pm